DrugPatentWatch Database Preview

Validus Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for VALIDUS PHARMS, and what generic alternatives to VALIDUS PHARMS drugs are available?

VALIDUS PHARMS has eight approved drugs.

There is one US patent protecting VALIDUS PHARMS drugs.

There is one patent family member on VALIDUS PHARMS drugs in one country.

Summary for Validus Pharms

International Patents:	1
US Patents:	1
Tradenames:	5
Ingredients:	5
NDAs:	8

Drugs and US Patents for Validus Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983		DISCN	Yes	No
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	AB	RX	Yes	No
Validus Pharms	ROCALTROL	calcitriol	CAPSULE;ORAL	018044-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No

Expired US Patents for Validus Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	3,800,534
Validus Pharms	ROCALTROL	calcitriol	CAPSULE;ORAL	018044-002	Approved Prior to Jan 1, 1982	3,697,559
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	3,806,534

Paragraph IV (Patent) Challenges for VALIDUS PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Capsules	200 mg and 300 mg		2007-08-21
	Extended-release Capsules	100 mg		2014-05-23

International Patents for Validus Pharms Drugs

Country	Document Number	Estimated Expiration
Canada	2452588

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Validus Pharms
• Validus Pharms Inc